Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05764681 · ClinicalTrials.gov registry record
Chronic Postsurgical Pain
A clinical trial of Cerebral Palsy and Chronic Post Surgical Pain, sponsored by Chantel Burkitt.
- Recruiting
- Registry status
- 500
- Enrollment target
- 2
- Study locations
NCT05764681: Recruiting study of Cerebral Palsy and Chronic Post Surgical Pain, sponsored by Chantel Burkitt.
NCT05764681 is a study of Cerebral Palsy and Chronic Post Surgical Pain that is actively recruiting participants, run by Chantel Burkitt. The registered enrollment target is 500 participants, above the 224-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (123% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05764681, a study of Cerebral Palsy and Chronic Post Surgical Pain, is actively recruiting participants, sponsored by Chantel Burkitt.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study purpose is to document the typical trajectory of perioperative pain experience in Cerebral Palsy (CP) and to identify important predictive factors for the development of chronic postsurgical pain. The main aims of the investigators are to: 1. Quantify the trajectory of pain and opioid use in the context of orthopedic surgery in children with CP. 2. Identify predictors for CPSP in children with CP and develop an applicable risk index. 3. Examine relationships between perioperative pain severity and functional/mobility outcomes achieved by orthopedic surgery in children with CP. Participants will complete: 1. Questionnaires/Surveys via email and text message 2. In-person Sensory Tests 3. In-person Gait and Motion Analysis
Primary Outcome
The BPI assesses pain location, pain intensity at worst, least, average, and right now as well as the degree to which pain interferes with activities of daily living (e.g., sleep, relationships, and mobility). Items are scored on an 11-point scale (0 = does not interfere, 10 = completely interferes) creating a total interference score ranging from 0-120 (higher scores mean more pain interference). The BPI has been adapted for and tested with individuals with severe CP, resulting in excellent int
Conditions Studied
Study Locations (2)
Delaware
- Nemour's Children's Hospital - Wilmington
Minnesota
- Gillette Children's Specialty Healthcare - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-03-17 |
| Est. Completion | 2029-01 |
What NCT05764681 shows while recruiting
NCT05764681 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 224-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (123% higher).
The record links to 2 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 0 interventions.
NCT05764681 reports a single indexed study location in Delaware, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05764681 about?
NCT05764681 is a clinical study titled "Chronic Postsurgical Pain". The study purpose is to document the typical trajectory of perioperative pain experience in Cerebral Palsy (CP) and to identify important predictive factors for the development of chronic postsurgical pain. The main aims of the investigators are to: 1. Quantify the trajectory of pain and opioid use...
What is the current status of trial NCT05764681?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2023-03-17. Estimated completion is 2029-01.
What conditions does trial NCT05764681 study?
This clinical trial studies the following conditions: Cerebral Palsy, Chronic Post Surgical Pain.
Who is sponsoring clinical trial NCT05764681?
This trial is sponsored by Chantel Burkitt, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05764681 being conducted?
This trial has 2 study locations across Delaware, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Palsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05764681's enrollment target sits among peer trials
500 5th of 91 higher than 86 of 91 other Cerebral Palsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stand-on Ride-on Power Mobility Devices for Children With Cerebral Palsy
RECRUITING · Early Phase 1
-
Motor Training for Infants With Cerebral Palsy
RECRUITING · NA
-
Implementation of Therapy Together
RECRUITING · NA
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy
RECRUITING · NA
-
Evaluation of Brain MRI Changes in Cerebral Palsy Patients
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI